Minerva Neurosciences, Inc. (NERV)
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.
Address
1601 TRAPELO ROAD
WALTHAM, MA 02451
Founded
2007
Number of Employees
9
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)